Table 1. Microsatellite repeat expansion disorders.
Disorder | Gene | Sense repeat | Antisense repeat | Disease length | Location in gene | RAN translated proteins | References |
---|---|---|---|---|---|---|---|
PolyQ microsatellite repeat expansion disorders: | |||||||
Dentatorubropallidoluysian Atrophy (DRPLA) | ATN1/DRPLA | CAG | Unknown | 49–88 | Exon 5 | Unknown | [127] |
Schizophrenia/migraines | KCNN3 | CAG | Unknown | >28 | Exon 1 | Unknown | [128] |
Prostate/breast Cancer | AIB/SRC-3 | CAG/CAA | Unknown | >23 | Exon 20 | Unknown | [129] |
Huntington's Disease (HD) | HTT | CAG | CTG | 36–250 | Exon 1 | polyS, polyA, polyC, polyL in human brains & in vitro3 | [2,52] |
Spinal and Bulbar Muscular Atrophy (SBMA) | AR | CAG | Unknown | 38–62 | Exon 1 | Unknown | [130] |
Spinocerebellar Ataxia Type 1 (SCA1) | ATXN1 | CAG | Unknown | 49–88 | Exon 8 | Unknown | [131] |
Spinocerebellar Ataxia Type 2 (SCA2) | ATXN2 | CAG | CTG | 33–77 | Exon 1 | polyQ, polyA, polyS in vitro3 | [132,133] |
Spinocerebellar Ataxia Type 3 (SCA3) or Machado-Joseph Disease (MJD) | ATXN3/MJD | CAG | CTG | 55–86 | Exon 10 | polyQ, polyA, polyS in vitro3 | [45,108,134] |
Spinocerebellar Ataxia Type 6 (SCA6) | CACNA1A | CAG | Unknown | 21–30 | Exon 47 | Unknown | [135] |
Spinocerebellar Ataxia Type 7 (SCA7) | ATXN7 | CAG | Unknown | 28–120 | Exon 3 | Unknown | [136] |
Spinocerebellar Ataxia Type 17 (SCA17) | TBP | CAG/CAA | Unknown | 47–63 | Exon 3 | Unknown | [137] |
Non-polyQ microsatellite repeat expansion disorders: | |||||||
Amyotrophic lateral sclerosis (ALS)/Frontotemporal Dementia (FTD) | C9ORF72 | GGGGCC | CCCCGG | 30–4400 | Intron 1 | polyGA, polyGP, polyGR, polyPA, polyPR in human brains & in vitro3 | [11,12,49–51,120] |
Baratela-Scott Syndrome | XYLT1 | GGC | Untranscribed expansion | >100 | Promoter | Unknown | [138] |
Blepharophimosis-Ptosis-Epicanthus Inversus Syndactylyl | FOXL2 | GCG | Unknown | 22–24 | Exon 1 | Unknown | [139] |
Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS) | RFC1 | AAGGG | Unknown | 400–2000 | Intron 2 | Unknown | [140] |
Cleidocranial Dysplasia | RUNX2/CBFA1 | GCG | Unknown | >20 | Exon 1 | Unknown | [141] |
Congenital Central Hypoventilation/Haddad Syndrome | PHOX2B | GCG | Unknown | 5–13 | Exon 3 | Unknown | [142] |
Familial adult myoclonic epilepsy (FAME1/BAFME1) | SAMD12 | TTTCA/TTTTA | Unknown | 440–3680 | Intron 4 | Unknown | [143] |
Fragile X syndrome (FRAXA/FXS) | FMR1 | CGG | CCG | >230 | 5′-UTR | Unknown | [6] |
Fragile X-associated tremor/ataxia syndrome (FXTAS) | FMR1 | CGG | CCG | 55–200 | 5′-UTR | polyG, polyP, polyA, polyR in vitro3 and Drosophila | [46,144,145] |
Fragile X-associated Primary Ovary Insufficiency (FXPOI) | FMR1 | CGG | Not found1 | 55–200 | 5′-UTR | polyG in biopsied human ovarian stromal cells | [146,147] |
Fragile XE mental retardation (FRAXE) | AFF2/FMR2 | CGG/CCG | Untranscribed expansion | >200 | Promoter | Unknown | [17] |
Fragile XF syndrome (FRAXF) | TMEN185A | GCC | Unknown | 300–500 | 5′-UTR | Unknown | [148] |
FRA2A-associated mental retardation | AFF3 | CGG | Unknown | >300 | 5′-UTR | Unknown | [19] |
FRA7A-associated autism spectrum disorder | ZNF713 | CGG | Unknown | >85 | Intron 1 | Unknown | [19] |
FRA10A-associated mental retardation | FRA10AC1 | CGG | Unknown | >200 | 5′-UTR | Unknown | [20] |
FRA11A-associated mental retardation | C11ORF80 | CGG | Unknown | 500 | 5′UTR | Unknown | [149] |
FRA12A-associated mental retardation | DIP2B | CGG | Unknown | >50 | 5′-UTR | Unknown | [21] |
FRA16A-associated mental retardation | LOC109617027 | CGG | Unknown | 1000–1900 | 5′-UTR | Unknown | [150] |
Friedreich's ataxia (FRDA) | FXN/X25 | GAA | TTC | >100 | Intron 1 | Unknown | [10] |
Fuchs’ Endothelial Corneal Dystrophy (FECD) | TCF4 | CTG | CAG | >50 | Intron 3 | polyC in human corneal endothelium + polyA, polyQ, polyS in vitro3 | [151,152] |
Hand-Foot-Genital Syndrome | HOXA13 | GCG | Unknown | 24–26 | Exon 1 | Unknown | [153] |
Holoprosencephaly | ZIC2 | GCG | Unknown | >25 | Exon 3 | Unknown | [154] |
Huntington Disease-Like 2 (HDL2) | JPH3 | CAG | CTG | >41 | 3′-terminal exon | polyQ, polyA, polyS in vitro3 | [45,155] |
Jacobsen Syndrome | FRA11B/CBL2 | CGG | Not found1 | 100–1000 | 5′-UTR | Unknown | [156] |
Myoclonus Epilepsy of the Unverricht-Lundborg Type | CYSTB | CCCCGCCCCGCG | Untranscribed expansion | 12–13 | Promoter | Unknown | [18] |
Congenital Myotonic Dystrophy (CDM)/Steinert's Disease | DMPK | CTG | CAG | 50–10000 | 3′-UTR | Unknown | [157] |
Myotonic dystrophy (DM1) | DMPK | CTG | CAG | 50–10000 | 3′-UTR | polyQ in human muscle/blood + polyA, polyS in vitro3 | [7,8,45,157] |
Myotonic dystrophy type 2 (DM2) | ZNF9 | CCTG | GGAC | 75–1100 | Intron 1 | polyQAGRpolyLPAC in human brains & in vitro3 | [106,158] |
Neuronal Intranuclear Inclusion Disease (NIID) & Amyotrophic lateral Sclerosis (ALS) | NOTCH2NLC | GGC | Unknown | >71 | 5′-UTR | Unknown | [159,160] |
Oculopharyngeal Musclar Dystrophy | PABPN1/PABP2 | GCG | Unknown | 12–17 | Exon 1 | Unknown | [161] |
Pseudoachrondroplasia and Multple Epiphyseal Displaysia (PSACH/MED) | COMP | GAC | Not found1 | >6 | Exon 13 | Unknown | [162] |
Spinocerebellar Ataxia Type 8 (SCA8) | ATXN8OS & ATXN8 | CTG | CAG | 110–250 | 3′-UTR ATXN8OS; 5′UTR ATXN8 | polyA in human brains + polyS, polyQ in vitro3 | [15,45] |
Spinocerebellar ataxia Type 10 (SCA10) | ATXN10 | ATTCT | Not found1 | 32–4000 | Intron 9 | Unknown | [163] |
Spinocerebellar ataxia Type 12 (SCA12) | PPP2R2B | CAG | CTG | 66–78 | 5′-UTR | Unknown | [164] |
Spinocerebellar ataxia Type 31 (SCA31) | BEAN1 | TGGAA | TTCCA | >110 | Intron 1 | polyWNGME?2 in vitro3 | [165] |
Spinocerebellar ataxia Type 36 (SCA36) | NOP56 | GGCCTG | Unknown | >100 | Intron 1 | polyGP, polyPR in human brains + polyGL, polyWA in vitro3 | [166,167] |
Spinocerebellar ataxia Type 37 (SCA37)4 | DAB1 | ATTTC | GAAAT | 31–75 | 5′-UTR | Unknown | [168] |
Synpolydactylyl Type II (SPD) | HOXD13 | GCG | Unknown | 22–29 | Exon 1 | Unknown | [169] |
X-Linked Dystonia-Parkinsonism (XPD)5 | TAF1 | CCCTCT | Unknown | 35–52 | Intron 32 | Unknown | [170] |
X-Linked Mental Retardation and Abnormal Genitalia (XLAG) | ARX | GCN | Unknown | 20 | Exon 2 | Unknown | [171] |
X-Linked Mental Retardation (XMLR) | ARX | GCN | Unknown | 18–23 | Exon 2 | Unknown | [172] |
X-linked Mental Retardation with Growth Hormone Deficiency (XLMRGHD) | SOX3 | GCN | Unknown | 15–26 | Exon 1 | Unknown | [173] |
Not found indicates that antisense transcripts were not detected;
The polypeptide polyWNGME is produced from the intronic repeat expansion, however it can not be confirmed as a RAN translation product due to the presence of an ATG sequence encoding a canonical AUG start codon within the repeat expansion;
In vitro indicates that the RAN-translated proteins were detected from reporter constructs in transfected cell model of diseases;
Not classical expansions but insertions due to replication/recombination/duplication events;
Not classical expansion but insertion due to retrotransposon event.